Showing posts with label DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM. Show all posts
Showing posts with label DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM. Show all posts

Monday, August 31, 2009


DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM

Anticoagulants
Prototype :
- Heparin (SQ and IV)
Warfarin (Orally)
Mechanism of actions :
a. Heparin
- prevents thrombin from converting fibrinogen to fibrin.
b. Warfarin
- suppress coagulation by acting as an
antagonist of vitamin K after 4-5 days.

Hemostasis :

Bleeding/injury
I
Vasoconstriction Plasminogen
I I
Platelet aggregation Plasmin
( temporary plug) I
I I
Clotting factor activation -------------- I
I I I
Intrinsic pathway (8,9,10,11,12) Extrinsic pathway (3,7,10) I
(PTT ) (PT) Vit K dep. I
I I I
I Prothrombin activation I I
I I
Thrombin I
I I
Fibrinogen ------------Fibrin threads ------------- Fibrin split products
(coagulation) ( Removed by liver & spleen )

Indications :
- thrombosis, pulmonary embolism, myocardial infarction
Adverse effect :
- bleeding
Nursing considerations :
1. HEPARIN sodium
- if given SQ don’t aspirate or rub the injection site (above the scapula - best site).
- therapeutic level 1.5-2.5 times normal PTT;
normal PTT is 20-35 sec. = 50-85 sec.
- antidote : (protamine sulfate)

2. WARFARIN sodium (coumadin)
- warfarin is used for long-term .
- onset of action is 4-5 days.
- therapeutic level is 1.5-2.5 times normal PT;
normal PT = 9.6 -11.8 sec. = 25 - 30 sec.
INR = 2 - 3
- should be taken at the same time of the day to maintain at therapeutic level.
- reduce intake of green leafy vegetables.
- antidote : Vitamin K ( Aquamephyton)

Thrombolytics
Prototype :
Streptokinase, Urokinase
Mechanism of actions :
- activates plasminogen to generates plasmin (enzyme that dissolve clots).
Indications :
- use early in the course of MI (within 4-6 hours of the onset)
Nursing considerations :
- monitor bleeding
- antidote : Aminocarpic acid

Antiplatelet Medications
Prototype: aspirin, Dipyridamole (Persantin)
Clopidoigrel (Plavix), Ticlopidine
Mechanism of action :
- inhibit the aggregation of platelet thereby prolonging bleeding time.
Indications :
- used in the prophylaxis of long-term complication following M.I, coronary
revascularization, and thrombotic CVA.
Nursing considerations :
- Monitor bleeding time ( NV = 1-9 mins)
- Take the medication with food.

Cardiac Glycosides
Prototype:
- digoxin (Lanoxin) and digitoxin (Crystodigin)
Mechanism of actions :
- increase intracellular calcium, which causes the heart muscle fibers to contract more
efficiently, producing positive inotropic & negative chronotropic action.
Indications :
- use for CHF, atrial tachycardia and fibrillation
Nursing considerations :
- Monitor for toxicity as evidence by :
nausea, vomiting, anorexia, halo vision, confusion, bradycardia and heart blocks .
- Do not administer if pulse is less than 60 bpm.
- Should be caution in patient with hypothyroidism and hypokalemia.
- Antidote : Digi-bind
- Phenytoin is the drug of choice to manage
digitalis-induced arrhythmia.


Nitrates
Prototype :
- isosorbide dinitrate (Isordil)
- nitroglycerine (Deponit, Nitrostat)
Mechanism of action :
- produce vasodilatation including coronary artery.
Indications :
- angina pectoris, MI, peripheral arterial occlusive disease.
Adverse effects:
- headache, orthostatic hypotension .

Nursing Considerations :
1. Transdermal patch
- apply the patch to a hairless area using a new patch and different site each day.
- remove the patch after 12-24 hours, allowing 10-12 hours “patch free” each day to
prevent tolerance.
2. Sublingual medications :
- note the BP before giving the medication.
- offer sips of water before giving because dryness may inhibit absorption.
- one tablet for pain and repeat every 5 mins. for a total of three doses; if not relieved
after 15 mins., seek medical help.
- stinging or burning sensation indicates that the tablet is fresh.
- instruct patient not to swallow the pill
- sustained release medications should be swallowed and not to be crush.
- protect the pills from light.




Anti-arrhythmic Drugs
Class I (block Na channels)
IA - quinidine, procainamide
IB - lidocaine
IC - flecainamide
Class II (Beta-blockers)
propanolol, esmolol
Class III (block K channels)
amiodarone, bretylium
Class IV (block Ca channels)
verapramil, diltiazem
Nursing considerations :
1. Watch out for signs of CHF.
2. Have client weigh themselves and report
weight gain.
3. Watch out for signs of lidocaine toxicity :
- confusion and restlessness

Antilipemics
Prototype :
a. cholesterol-lowering agents
- cholestyramine, colestipol, lovastatin
b. triglyceride-lowering agents
- gemfibrozil, clofibrate
Mechanism of actions :
- interfere with cholesterol synthesis as well as
decreasing lipoprotein & triglyceride synthesis.
Nursing considerations :
- monitor liver functions while using statins.
- prevent constipation, flatulence, cholelithiasis
- encourage increase fluid and fiber intake.

ANTI – HYPERTENSIVE

Angiotensin-Converting Enzyme (ACE) Inhibitors
Prototype :
captopril (Capoten), enalapril (Vasotec), quinapril, lisinopril
Mechanism of actions :
- prevent peripheral vasoconstriction by blocking conversion of angiotensin I to
angiotensin II decreasing peripheral resistance.
Adverse effect :
- it cause hyperkalemia
- induce chronic cough
Nursing considerations :
- not to discontinue medications because it can cause rebound hypertension.
- avoid using K+ sparing diuretics.

Calcium-Channel Blockers
Prototype :
- Nifedipine (calcibloc, adalat), Amlodipine (norvasc), Felodipine (Plendil)
Verapramil (Isoptin)
Mechanism of action :
- decrease cardiac contractility and the workload of the heart, thus decreasing the
need for O2.
- it also promote vasodilatation of the coronary and peripheral vessels.
Indications :
- hypertension, angina, arrhythmia
Adverse effects :
- bradycardia, hypotension, headache
- reflex tachycardia, constipation
Nursing considerations :
- Administer between meals to enhance absorption.
- Take client’s pulse rate before each dose, withhold if pulse is below 60 bpm.
- Refer for signs of congestive heart failure.

Diuretics
- usually given at morning
CARBONIC ANHYDRASE INHIBITORS
- Acetazolimide (Diamox)
- increase Na+, K+, & HCO3 secretion, along with it is H2O
- metabolic acidosis
OSMOTIC DIURETIC
- Mannitol
- Increase osmotic pressure of the glomerular filtrate.
- hypotension
THIAZIDE DIURETICS
- hydrochlorothiazide
- blocks Na and K reabsorption; reabsorb Ca
- hypercalcemia
LOOP DIURETICS
- Furosemide (Lasix)
- blocks Na, K, and Ca reabsorption
- hypocalcemia
POTASSIUM SPARING DIURETICS
- Spironolactone (Aldactone)
- excrete Na and water but it reabsorb K
- hyperkalemia

Read more...
free counters

About This Blog

  © Blogger template Cumulus by Ourblogtemplates.com 2008

Back to TOP